DCCAX
Price
$34.73
Change
+$0.07 (+0.20%)
Updated
Jul 31 closing price
Net Assets
5.43B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

DCCAX vs VSMAX

DCCAX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
DCCAX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCCAX is a Buy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. DCCAX (5.43B). VSMAX pays higher dividends than DCCAX: VSMAX (1.21) vs DCCAX (0.23). DCCAX was incepted earlier than VSMAX: DCCAX (28 years) vs VSMAX (26 years). DCCAX (1.04) is less costly to investors than VSMAX (0.05). DCCAX is a more actively managed with annual turnover of: 26.00 vs. VSMAX (17.00). DCCAX has a lower initial minimum investment than VSMAX: DCCAX (1000) vs VSMAX (3000). VSMAX (22.58) and DCCAX (21.68) have marching annual gain over last year. VSMAX return over 5 years is better than : 35.11 vs. DCCAX (14.44).
DCCAXVSMAXDCCAX / VSMAX
Total Expense Ratio1.040.052,080%
Annual Report Gross Expense Ratio1.040.052,080%
Fund Existence28 years26 years-
Gain YTD17.80914.588122%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.43B189B3%
Annual Yield % from dividends0.231.2119%
Returns for 1 year21.6822.5896%
Returns for 3 years27.8243.4264%
Returns for 5 years14.4435.1141%
Returns for 10 years78.71155.9650%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H